Drug development
The development of biotechnologically produced drugs has made it possible to treat diseases at their cause, to do this more efficiently and with fewer side effects, or even to cure diseases. This is the focus of five biotechnology companies on Campus Berlin-Buch.
The spectrum of their drug development includes highly specific cancer antibodies (Glycotope GmbH), novel treatments targeting the cause of heart failure (Berlin Cures GmbH) or atrial fibrillation (OMEICOS Therapeutics GmbH), extremely effective antibiotics (MerLion Pharmaceuticals) and RNAi-based therapeutics for systemic cancers that can selectively regulate disease-related genes (Silence Therapeutics). Here, T-Knife, a spin-off from the Charité and the Max Delbrück Center, is developing one of the first T cell receptor gene therapies in Germany.
News innovation
Inspiring and connecting: “Talk im Cube”
For almost a year, “Talk im Cube” has been bringing science and business together on the Campus Berlin-Buch
more ...Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments
Eckert & Ziegler, one of the world’s largest providers of isotopes for medical, scientific and industrial use, and Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceuti...
more ...Eckert & Ziegler: Changes in the Executive Board and Supervisory Board
The Supervisory Board of Eckert & Ziegler SE has appointed Dr. Gunnar Mann (57) as a new member of the Executive Board, effective 1 January 2025. He will assume operational responsibility for the Medi...
more ...Events Campus
17.12.2024, 08:00
Aktualisierungskurs für Projektleiter und Beauftragte für Biologische Sicherheit nach § 28 GenTSV
In Deutschland müssen Projekteiter und Beauftragte für Biologische Sicherheit gemäß § 28 Abs. 3 der aktuellen Gentechnik Sicherheitsverordnung (GenTSV) ihre Kenntnisse „mindestens alle fünf Jahre durc...
more ...07.01.2025, 16:00
Krebs und Metastasierung: Ursachen und neue Therapien
26.02.2025, 10:00
JUGEND FORSCHT – 60. Regional-Wettbewerb „Macht aus Fragen Antworten”
Die Pateneinrichtungen des Campus Berlin-Buch richten erneut den Regionalwettbewerb aus
more ...
